ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
217.14
-4.88 (-2.20%)
At close: Apr 28, 2026, 4:00 PM EDT
218.00
+0.86 (0.40%)
After-hours: Apr 28, 2026, 7:47 PM EDT
ResMed Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ResMed stock have an average target of 292.56, with a low estimate of 265 and a high estimate of 340. The average target predicts an increase of 34.73% from the current stock price of 217.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 6 | 5 | 5 | 5 | 5 | 5 |
| Hold | 4 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $302 → $290 | Buy | Maintains | $302 → $290 | +33.55% | Apr 27, 2026 |
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 15, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $345 → $340 | Strong Buy | Maintains | $345 → $340 | +56.58% | Apr 9, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $330 → $345 | Strong Buy | Maintains | $330 → $345 | +58.88% | Feb 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $311 → $314 | Buy | Maintains | $311 → $314 | +44.61% | Jan 30, 2026 |
Financial Forecast
Revenue This Year
5.69B
from 5.15B
Increased by 10.60%
Revenue Next Year
6.11B
from 5.69B
Increased by 7.41%
EPS This Year
11.11
from 9.51
Increased by 16.84%
EPS Next Year
12.28
from 11.11
Increased by 10.50%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.0B | 6.5B | |||
| Avg | 5.7B | 6.1B | |||
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.1% | 13.8% | |||
| Avg | 10.6% | 7.4% | |||
| Low | 6.6% | 2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.78 | 13.40 | |||
| Avg | 11.11 | 12.28 | |||
| Low | 10.14 | 11.47 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.9% | 20.6% | |||
| Avg | 16.8% | 10.5% | |||
| Low | 6.7% | 3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.